$6.01
-0.47 (-7.25%)
Cornerstone Therapeutics Inc. (NASDAQ:CRTX)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
RSS Headlines
Fool UK